APO PHARM ApS: Financial statements 2025
CVR: 15226072
Source: annual report 2025, Danish Business Authority
01/07/2024 – 30/06/2025
APO PHARM ApS (CVR 15226072) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. That is a decrease of 2.7% compared with the year before. Equity in the 2025 report amounted to DKK 332,307. The solvency ratio was 18.4%. The company had 5 employees in the financial year.
- Gross Profit
- DKK 1,481,073
- Profit/Loss
- DKK 26,824
- Equity
- DKK 332,307
- Total Assets
- DKK 1,810,295
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 1.5 mio. | 27 t. | 332 t. | 5 |
| 2024 | - | 1.5 mio. | 121 t. | 505 t. | 5 |
| 2023 | - | 1.4 mio. | 293 t. | 684 t. | 4 |
| 2022 | - | 1.3 mio. | 254 t. | 691 t. | 6 |
| 2021 | - | 1.7 mio. | 566 t. | 1 mio. | 6 |
Official annual report
How creditworthy is APO PHARM ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout APO PHARM ApS
APO PHARM ApS is a Danish company of the type Anpartsselskab based in Holbæk, founded in 1991. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named VITALISTEN ApS. The management consists of Helge Larsen. The board consists of Hanne Vesti Petersen and Helge Larsen. The company is owned by VESTI LARSEN ApS. The company has 7 employees (2026). In 2025, the company reported a gross profit of DKK 1,481,073 and a net result of DKK 26,824 compared with DKK 121,257 the year before. Equity in the 2025 report amounted to DKK 332,307.